FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Automated Insulin Dosing Device System, Single Hormonal Control

PMA: P160017 · Supplement: S082 · Decision Apr 16, 2020
Classifications
1
FEI Numbers
16
Registration Numbers
16

Basic Information

Device Name
Automated Insulin Dosing Device System, Single Hormonal Control
Trade Name
MiniMed 670G Insulin Pump
PMA Number
P160017
Supplement Number
S082
Device Class
FDA Class 3
Product Code
OZP
Generic Name
Automated insulin dosing device system, single hormonal control
Medical Specialty
Unknown
Advisory Committee
Clinical Chemistry
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
April 16, 2020
Date Received
March 30, 2020
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

New reclamation process to allow printed circuit board assemblies to be re-used for construction of refurbished 630G and 670G insulin pumps. The 630G and 670G insulin pumps are components of the MiniMed 630G and MiniMed 670G systems, respectively.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OZP Automated Insulin Dosing Device System, Single Hormonal Control